Nothing Special   »   [go: up one dir, main page]

K El-Baz et al., 2023 - Google Patents

Potential production of omega fatty acids from Scenedesmus obliquus microalgae: Evaluation of acute and chronic toxicity

K El-Baz et al., 2023

View PDF
Document ID
6122947660435883657
Author
K El-Baz F
Salah D
Abougharam G
Ali S
Aly H
Publication year
Publication venue
Egyptian Journal of Chemistry

External Links

Snippet

Background: Omega-3 fatty acids (O3FA) as dietary supplements for medical use improve health. Methods: Acute and chronic toxicity were done using male and female rats. Results of acute toxicity showed no behavioral alterations, toxicity, or mortality in treated animals at a …
Continue reading at ejchem.journals.ekb.eg (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having 2 or more double bonds in their backbone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae

Similar Documents

Publication Publication Date Title
JP6705599B2 (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making them and their use
JP5491697B2 (en) Composition comprising high level omega-3 and low level saturated fatty acids
JP5546087B2 (en) Oral treatment or prevention agent for skin diseases
Sayeda et al. Potential production of omega fatty acids from microalgae
Choopani et al. Spirulina: a source of gamma-linoleic acid and its applications
Dąbrowski et al. Update on food sources and biological activity of odd-chain, branched and cyclic fatty acids––A review
Robertson et al. Algae-derived polyunsaturated fatty acids: implications for human health
Calviello et al. Dietary omega-3 polyunsaturated fatty acids and cancer
US20220233488A1 (en) Very long chain fatty acids for treatment and alleviation of diseases
Mimouni et al. Marine microalgae used as food supplements and their implication in preventing cardiovascular diseases
Yang et al. Technological readiness of commercial microalgae species for foods
Qiu et al. Biosafety evaluation of Nannochloropsis oculata and Schizochytrium sp. oils as novel human milk fat substitutes
K El-Baz et al. Potential production of omega fatty acids from Scenedesmus obliquus microalgae: Evaluation of acute and chronic toxicity
El-Baz et al. http://ejchem. journals. ekb. eg
Jang et al. Immune-modulation effect of Halocynthia aurantium tunic lipid on RAW264. 7 cells
WO2011067666A1 (en) Processes to generate compositions of enriched fatty acids
Singh et al. Biotechnological application of algae in pharmaceuticals industries with special reference to omega-3 fatty acid and human health
Sahin Effect of oil extract from microalgae (Schizochytrium sp.) on the viability and apoptosis of human osteosarcoma cells
JP6203320B2 (en) Oral treatment or prevention agent for skin diseases
Ferreri Omega 3 fatty acids and bioactive foods: from biotechnology to health promotion
JP2012082226A (en) Oral agent for treatment or prevention of cutaneous disease
EP2079824B1 (en) Modified alkoxyglycerols
WO2023145785A1 (en) Thrombosis preventive agent
JP6462790B2 (en) Oral treatment or prevention agent for skin diseases
Singh et al. 3 BiotechnologicalofAlgaein Pharmaceuticals Application Industries with Special Reference to Omega-3 Fatty Acid and Human Health